Innate and adaptive immune signaling networks

Innate and adaptive immune signaling networks comprise the intricate web of biochemical pathways and cellular interactions that coordinate the body's defense against pathogens and maintain tissue homeostasis (Janeway's Immunobiology). The innate component provides rapid, non-specific responses via pattern recognition receptors like Toll-like receptors (TLRs), while the adaptive component offers highly specific, long-lasting immunity through T and B cell activation (NIH - National Institute of Allergy and Infectious Diseases). These systems are linked by antigen-presenting cells and a vast array of cytokines and chemokines that facilitate crosstalk between the two arms of the immune system. Dysregulation of these networks is a hallmark of numerous pathologies, including rheumatoid arthritis, multiple sclerosis, and various malignancies where the immune system either overreacts to self-antigens or fails to recognize transformed cells (Nature Reviews Immunology). Pharmacological modulation of these networks is a cornerstone of modern medicine, utilizing biologics and small molecules to target specific signaling nodes like cytokines (e.g., TNF-alpha), kinases (e.g., JAK), and checkpoint receptors (e.g., PD-1) to restore balance or stimulate a response (PubMed - PMID: 30237530). Because this term refers to a broad system of pathways rather than a single protein or receptor, it is classified as a network rather than a discrete therapeutic target.

Other names

Immune signaling pathwaysInnate-adaptive crosstalkImmune system networksImmune response signaling

Modulation of specific molecular nodes such as cytokines, pattern recognition receptors, kinases, or immune checkpoints to either suppress pathological inflammation or enhance anti-tumor immunity.